{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:12:37Z","timestamp":1790284357623,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012556","name":"Foundation for Innovative Research Groups of Hubei Province of China","doi-asserted-by":"publisher","award":["2023AFA036"],"award-info":[{"award-number":["2023AFA036"]}],"id":[{"id":"10.13039\/501100012556","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2704200"],"award-info":[{"award-number":["2022YFC2704200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2704205"],"award-info":[{"award-number":["2022YFC2704205"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272707"],"award-info":[{"award-number":["82272707"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372928"],"award-info":[{"award-number":["82372928"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82441045"],"award-info":[{"award-number":["82441045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072889"],"award-info":[{"award-number":["82072889"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005984","name":"Dr. Miriam and Sheldon G. Adelson Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005984","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Resistance Updates"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.drup.2025.101319","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:09:14Z","timestamp":1761696554000},"page":"101319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer"],"prefix":"10.1016","volume":"84","author":[{"given":"Shen-nan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengshi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8308-7786","authenticated-orcid":false,"given":"Yuewen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanjia","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyne","family":"Labrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0151-0822","authenticated-orcid":false,"given":"Zhiyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0144-9614","authenticated-orcid":false,"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3112-7595","authenticated-orcid":false,"given":"Guang-Nian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7267","key":"10.1016\/j.drup.2025.101319_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101319_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101287","article-title":"Targeting DNA damage response pathways in tumor drug resistance: Mechanisms, clinical implications, and future directions","volume":"83","author":"Zhu","year":"2025","journal-title":"Drug Resist Update"},{"issue":"7779","key":"10.1016\/j.drup.2025.101319_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/s41586-019-1659-4","article-title":"Stabilization of chromatin topology safeguards genome integrity","volume":"574","author":"Ochs","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.drup.2025.101319_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41568-022-00535-5","article-title":"Targeting DNA damage response pathways in cancer","volume":"23","author":"Groelly","year":"2023","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.drup.2025.101319_bib5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41580-019-0152-0","article-title":"DNA double-strand break repair-pathway choice in somatic mammalian cells","volume":"20","author":"Scully","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.drup.2025.101319_bib6","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrm.2017.48","article-title":"Non-homologous DNA end joining and alternative pathways to double-strand break repair","volume":"18","author":"Chang","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.drup.2025.101319_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41573-022-00558-5","article-title":"Targeting replication stress in cancer therapy","volume":"22","author":"Da","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.drup.2025.101319_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrm3047","article-title":"The MRE11 complex: starting from the ends","volume":"12","author":"Stracker","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.drup.2025.101319_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the Trinity at the Heart of the DNA Damage Response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"issue":"14","key":"10.1016\/j.drup.2025.101319_bib10","doi-asserted-by":"crossref","first-page":"9558","DOI":"10.1074\/jbc.M808906200","article-title":"Human CtIP mediates cell cycle control of DNA end resection and double strand break repair","volume":"284","author":"Huertas","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drup.2025.101319_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-genet-071719-020312","article-title":"DNA End Resection: Mechanism and Control","volume":"55","author":"Cejka","year":"2021","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.drup.2025.101319_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101085","article-title":"Syk-dependent homologous recombination activation promotes cancer resistance to DNA targeted therapy","volume":"74","author":"Zhou","year":"2024","journal-title":"Drug Resist Update"},{"issue":"11","key":"10.1016\/j.drup.2025.101319_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41568-021-00386-6","article-title":"Targeting the DNA damage response in immuno-oncology: developments and opportunities","volume":"21","author":"Chabanon","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"7668","key":"10.1016\/j.drup.2025.101319_bib14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature23470","article-title":"Mitotic progression following DNA damage enables pattern recognition within micronuclei","volume":"548","author":"Harding","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.drup.2025.101319_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"7918","key":"10.1016\/j.drup.2025.101319_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41586-022-04847-2","article-title":"cGAS-STING drives the IL-6-dependent survival of chromosomally instable cancers","volume":"607","author":"Hong","year":"2022","journal-title":"Nature"},{"issue":"7668","key":"10.1016\/j.drup.2025.101319_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"cGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"issue":"7729","key":"10.1016\/j.drup.2025.101319_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-018-0629-6","article-title":"Nuclear cGAS suppresses DNA repair and promotes tumorigenesis","volume":"563","author":"Liu","year":"2018","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.drup.2025.101319_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202102534","article-title":"Nuclear AIM2-like receptors drive genotoxic tissue injury by inhibiting DNA repair","volume":"8","author":"Jiang","year":"2021","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.drup.2025.101319_bib20","doi-asserted-by":"crossref","first-page":"4126","DOI":"10.1038\/s41467-021-24341-z","article-title":"DHX9-dependent recruitment of BRCA1 to RNA promotes DNA end resection in homologous recombination","volume":"12","author":"Chakraborty","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.drup.2025.101319_bib21","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41467-021-22484-7","article-title":"Reciprocal regulation of RIG-I and XRCC4 connects DNA repair with RIG-I immune signaling","volume":"12","author":"Guo","year":"2021","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.drup.2025.101319_bib22","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1074\/jbc.M109488200","article-title":"Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3","volume":"277","author":"Sun","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.drup.2025.101319_bib23","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221156","article-title":"The Z-nucleic acid sensor ZBP1 in health and disease","volume":"220","author":"Maelfait","year":"2023","journal-title":"J. Exp. Med"},{"issue":"7152","key":"10.1016\/j.drup.2025.101319_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature06013","article-title":"DAI (DLM-1\/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response","volume":"448","author":"Takaoka","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.drup.2025.101319_bib25","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","article-title":"53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks","volume":"141","author":"Bunting","year":"2010","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.drup.2025.101319_bib26","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0092-8674(01)00335-X","article-title":"Structural biochemistry and interaction architecture of the DNA double-strand break repair Mre11 nuclease and Rad50-ATPase","volume":"105","author":"Hopfner","year":"2001","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.drup.2025.101319_bib27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrm805","article-title":"The Mre11 complex: at the crossroads of dna repair and checkpoint signalling","volume":"3","author":"D'Amours","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"18","key":"10.1016\/j.drup.2025.101319_bib28","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1016\/j.cell.2024.06.013","article-title":"Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors","volume":"187","author":"Luo","year":"2024","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.drup.2025.101319_bib29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.annonc.2021.02.015","article-title":"The systemic treatment of recurrent ovarian cancer revisited","volume":"32","author":"Baert","year":"2021","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.drup.2025.101319_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.annonc.2021.11.013","article-title":"European experts consensus: BRCA\/homologous recombination deficiency testing in first-line ovarian cancer","volume":"33","author":"Vergote","year":"2022","journal-title":"Ann. Oncol."},{"issue":"7914","key":"10.1016\/j.drup.2025.101319_bib31","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","article-title":"ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis","volume":"606","author":"Zhang","year":"2022","journal-title":"Nature"},{"issue":"7676","key":"10.1016\/j.drup.2025.101319_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature24050","article-title":"Cytoplasmic chromatin triggers inflammation in senescence and cancer","volume":"550","author":"Dou","year":"2017","journal-title":"Nature"},{"issue":"7169","key":"10.1016\/j.drup.2025.101319_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nature06337","article-title":"Human CtIP promotes DNA end resection","volume":"450","author":"Sartori","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.drup.2025.101319_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2021.05.013","article-title":"MRE11 as a molecular signature and therapeutic target for cancer treatment with radiotherapy","volume":"514","author":"Wang","year":"2021","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.drup.2025.101319_bib35","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s43018-022-00429-3","article-title":"METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma","volume":"3","author":"Zeng","year":"2022","journal-title":"Nat. Cancer"},{"issue":"7732","key":"10.1016\/j.drup.2025.101319_bib36","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41586-018-0670-5","article-title":"DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells","volume":"563","author":"He","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.drup.2025.101319_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203884","article-title":"RNF126-mediated MRE11 ubiquitination activates the DNA damage response and confers resistance of triple-negative breast cancer to radiotherapy","volume":"10","author":"Liu","year":"2023","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.drup.2025.101319_bib38","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.molcel.2019.06.023","article-title":"C1QBP promotes homologous recombination by stabilizing MRE11 and controlling the assembly and activation of MRE11\/RAD50\/NBS1 complex","volume":"75","author":"Bai","year":"2019","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.drup.2025.101319_bib39","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.cell.2023.11.022","article-title":"Metabolic regulation of homologous recombination repair by MRE11 lactylation","volume":"187","author":"Chen","year":"2024","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.drup.2025.101319_bib40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cell.2018.11.024","article-title":"UBQLN4 represses homologous recombination and is overexpressed in aggressive tumors","volume":"176","author":"Jachimowicz","year":"2019","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.drup.2025.101319_bib41","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1158\/0008-5472.CAN-16-1272","article-title":"CRISPR\/Cas9-mediated Trp53 and Brca2 knockout to generate improved murine models of ovarian high-grade serous carcinoma","volume":"76","author":"Walton","year":"2016","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.drup.2025.101319_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkt1309","article-title":"Quantitation of DNA double-strand break resection intermediates in human cells","volume":"42","author":"Zhou","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.drup.2025.101319_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/or.2020.7890","article-title":"TELO2 induced progression of colorectal cancer by binding with RICTOR through mTORC2","volume":"45","author":"Guo","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.drup.2025.101319_bib44","article-title":"Effectiveness and safety of niraparib as neoadjuvant therapy in advanced ovarian cancer with homologous recombination deficiency (NANT): study protocol for a prospective, multicenter, exploratory, phase 2, single-arm study","volume":"12","author":"Zhou","year":"2022","journal-title":"Front. Oncol."}],"container-title":["Drug Resistance Updates"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1368764625001220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:58:18Z","timestamp":1773291498000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1368764625001220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":44,"alternative-id":["S1368764625001220"],"URL":"https:\/\/doi.org\/10.1016\/j.drup.2025.101319","relation":{},"ISSN":["1368-7646"],"issn-type":[{"value":"1368-7646","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ZBP1 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Drug Resistance Updates","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drup.2025.101319","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101319"}}